Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Study to Assess the Safety and Tolerability of Single and Multiple Doses of SNS851

NCT07417124 is registered in ClinicalTrials.gov with Oneness Biotech Co., Ltd. as lead sponsor.

NCT NCT07417124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07417124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Study to Assess the Safety and Tolerability of Single and Multiple Doses of SNS851
Lead sponsor
Oneness Biotech Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2026
Completion date
October 31, 2026
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disease